Anika Therapeutics Distributes HA-based Therapies Again

As expected, Anika Therapeutics resumed global distribution of HYALOFAST and HYALOGRAFT-C therapies for cartilage repair, following a 2Q18 voluntary product recall.

Following recent regulatory approvals in Colombia, Thailand and the United Arab Emirates, HYALOFAST is now commercialized in 5 countries–though not yet in the U.S., where it is...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us